Pulmonary Hypertension (PH) Terminated Phase 3 Trials for Bosentan (DB00559)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00302211The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial HypertensionTreatment
NCT00313196Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)Treatment
NCT00310830Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)Treatment
NCT00360087A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET StudyTreatment